Bigatra 110 mg Tablet

Bigatra 110 mg Tablet is a prescription anticoagulant that contains 110 mg of dabigatran etexilate in each tablet. It belongs to the direct oral anticoagulant (DOAC) class, which helps lower the risk of harmful blood clots. Doctors prescribe Bigatra 110 mg Tablet to help prevent stroke and blood clots in certain people, including some patients with atrial fibrillation and those being treated or prevented from recurrence of venous thromboembolism. Because it affects clotting, it must be used exactly as directed.

How it works: Dabigatran etexilate in Bigatra 110 mg Tablet is a prodrug that your body converts into dabigatran after you swallow the tablet. Dabigatran then blocks thrombin, a key clotting protein, which slows the formation of blood clots.

Bigatra 110 mg Tablet is a mid-strength option in this brand range, sitting between Bigatra 75 mg Tablet and Bigatra 150 mg Tablet. A doctor may choose Bigatra 110 mg Tablet when a standard dabigatran dose is appropriate but a lower strength is preferred for safety based on age, kidney function, bleeding risk, or other medical factors. It is not a starter or casual-use strength; it is selected after a clinician reviews your individual risks and benefits.

• Stroke prevention in atrial fibrillation
• Prevention and treatment of blood clots
• Reduction of recurrent deep vein thrombosis
• Reduction of recurrent pulmonary embolism

• Swallow the Bigatra 110 mg Tablet whole with a full glass of water; do not crush, chew, or break it.
• Take it at the same time each day if your doctor prescribes a once- or twice-daily schedule.
• You may take it with or without food unless your prescriber gives different instructions.
• Do not open the capsule contents inside this tablet form; keep the dose intact to preserve how the medicine is absorbed.
• If you miss a dose, follow your prescriber’s directions or the product instructions you were given; do not double up unless told to do so.
• Tell your doctor before any surgery, dental work, or invasive procedure, because dabigatran can increase bleeding.

Each Bigatra 110 mg Tablet provides 110 mg of dabigatran etexilate per tablet. Depending on the condition being treated and your kidney function, this strength may be taken once or twice daily; your doctor decides the exact schedule and whether a lower or higher strength is safer for you. The maximum daily amount depends on the indication and your prescriber’s plan, so do not change the dose on your own.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Dabigatran Etexilate may include:

• Easy bruising
• Nosebleeds
• Upset stomach
• Heartburn or indigestion
• Nausea
• Minor bleeding that may be a bit more noticeable with this anticoagulant

• Bigatra 110 mg Tablet is a higher-prescription anticoagulant strength and should only be used under a doctor’s supervision.
• Do not use it to treat sudden chest pain or a suspected blood clot emergency unless a clinician has specifically instructed you.
• People with kidney problems may need a different dose or may not be suitable for dabigatran.
• Avoid starting or stopping aspirin, NSAIDs, or other blood thinners without medical advice because bleeding risk can rise.
• Limit alcohol, which can increase bleeding risk and stomach irritation.
• Tell your doctor if you have a history of stomach ulcers, bleeding disorders, recent surgery, or a fall risk.
• Do not drive or use machinery if you feel dizzy, weak, or unwell after taking it.

• Other anticoagulants such as warfarin, apixaban, rivaroxaban, heparins, or fondaparinux
• Antiplatelet medicines such as aspirin, clopidogrel, prasugrel, or ticagrelor
• NSAIDs such as ibuprofen, naproxen, and diclofenac
• P-glycoprotein inhibitors such as dronedarone, ketoconazole, and verapamil
• Rifampin, which can reduce dabigatran levels

Store Bigatra 110 mg Tablet in its original strip/box at room temperature, away from moisture and heat, and keep it out of reach of children.